マイクロキャリアの世界市場予測（2022年～2027年）

世界のマイクロキャリアの市場規模は、2020年に7億4,375万米ドルとなり、予測期間中に11.55％のCAGRで成長し、2027年に15億9,806万6,000米ドルになると予測されています。市場を牽引する要因には、生物製剤およびバイオシミラー業界の急成長などが挙げられます。しかし、細胞生物製剤や細胞ベースの治療法のコストが高いことが、予測期間中の市場成長の妨げになる可能性があります。

当レポートでは、世界のマイクロキャリア市場について調査し、市場規模や予測、COVID-19の影響、市場の促進要因および課題、市場動向、セグメント別の市場分析、競合情勢、主要企業のプロファイルなどの体系的な情報を提供しています。

目次

第1章 イントロダクション

• 市場概要
• COVID-19の影響
• 市場の定義
• 市場セグメンテーション

第2章 調査手法

• 調査データ
• 前提条件

第3章 エグゼクティブサマリー

• 調査のハイライト

第4章 市場力学

• 市場促進要因
• 市場抑制要因
• ポーターのファイブフォース分析
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• 業界のバリューチェーン分析

第5章 マイクロキャリア市場”製品タイプ別

• イントロダクション
• 装置
• 消耗品
  • 試薬
  • マイクロキャリアビーズ
  • その他

第6章 マイクロキャリア市場：用途別

• イントロダクション
• バイオ医薬品生産
• 細胞・遺伝子治療
• その他

第7章 マイクロキャリア市場：エンドユーザー別

• イントロダクション
• 製薬・バイオテクノロジー企業
• 研究
• 受託研究機関

第8章 マイクロキャリア市場：地域別

• イントロダクション
• 北米
  • 米国
  • カナダ
  • メキシコ
• 南米
  • ブラジル
  • アルゼンチン
  • その他
• 欧州
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • その他
• 中東・アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • その他
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • インドネシア
  • その他

第9章 競合環境と分析

• 主要企業と戦略分析
• 新興企業と市場の有利性
• 合併、買収、契約、コラボレーション
• ベンダーの競合マトリックス

第10章 企業プロファイル

• Thermo Fisher Scientific
• Corning Incorporated
• Sartorious AG
• Pall Corporation
• Batavia Biosciences B.V.
• Primorigen Biosciences
• Cytiva
• Nucleus Biologics, LLC.
• Merck KGaA
• Entegris

The microcarrier market is projected to grow at a CAGR of 11.55% during the forecast period to reach US$1,598.066 million by 2027, from US$743.750 million in 2020.

Microcarriers are microscopic beads or spheres used to increase the surface area in tissue culture for the attachment and yield of anchorage-dependent cells and act as a support matrix, which allows the growth of adherent cells in bioreactors. Microcarriers are extensively used in the large-scale commercial production of biologics and vaccines to grow virus-generating or protein-producing adherent cell populations. The growth in the microcarriers market may be attributed to the rapid growth in the biologics and biosimilar industries. Rising demand for cell-based vaccines along with technological advancements will positively impact the market for microcarriers. However, the high cost of cell biologics and cell-based therapies might hamper the growth of the market during the given forecast period. Growth limitations of high-density microcarrier cultures will also restrain the growth of the microcarrier market during the anticipated period. Further, the microcarrier market is segmented into product, application, end-user, and geography.

The Microcarriers market will grow due to the rising demand for cell-based vaccines.

Due to the growing number of new virus outbreaks such as influenza, monkeypox, Ebola, and COVID-19 among others, the demand for vaccines is increasing globally, consequently increasing the demand for microcarriers in the market and supporting the growth of the microcarrier market during the forecast period. For instance, the World Health Organization's Disease Outbreak News (DONs), which provided confirmed acute public health events of potential events of concern reported an Ebola virus outbreak in the Democratic Republic of the Congo in September 2022. The Ministry of Health of the Democratic Republic of the Congo declared the outbreak following the confirmed laboratory test via RT-PCR in a fatal case in Beni Health Zone, North Kivu Province.

During the same period, Uganda also witnessed a confirmed 18 cases as of 25th September 2022 Ebola virus which were caused by Sudan Virus. Such increasing cases of infectious diseases and the growing risk of pandemics are the prime factors driving the demand for vaccines worldwide. Moreover, in June 2022, just after a few months of recovery from the disruptions of the COVID-19 pandemic, the outbreak of monkeypox in different countries alarmed the vaccine developer companies to take measures to control the spread of the new virus. Further, many organizations are putting efforts to develop vaccines for the rising disease. For instance, the Centers for Disease Control and Prevention (CDC) mentions in its Vaccine considerations summary updated in September 2022, that the JYNNEOS vaccine is approved for the prevention of monkeypox and smallpox diseases. Further, the ACAM2000 Vaccines has been approved for immunization against smallpox which is made available for use against monkeypox under Expanded Access Investigational New Drug protocol, mentions the CDC.

The microcarrier market is expected to be dominated by the North American region, which is expected to hold a significant share of the Microcarrier market. The rising research and development activities, gene therapies, and biologics, coupled with technological advancement and investment in cell-based research in the countries like the US. Additionally, the prevalence of established pharmaceutical companies, who continually work to expand their geographic reach and promote the widespread marketing of their vaccines, is anticipated to spur market expansion in this region. Moreover, this region will grow due to the increased need for immunizations during pandemics. due to the rise in the prevalence of infectious and cancerous illnesses. On the other hand, Europe holds the second largest share of the microcarrier market during the anticipated period owing to the increasing number of leading firms in the market and growing usage of technical innovations. It is anticipated that increased R&D utilization will enhance product development and market demand in this region.

Product offering

• Thermo Fisher Scientific offers the HarvestainerTM Microcarrier Separation system which is an ideal solution for the separation of microcarrier beads during adherent cell culture production. It is an ideal system for smaller-scale as well as larger-scale applications for in-line microcarrier separation. In comparison to conventional procedures, the system helps to boost product yields while lowering the need for clean-in-place, steam-in-place, and water for injection.
• Corning incorporated offers Corning® Microcarriers for Bioprocess scale-up that are designed to simplify the scale-up processes. The microcarriers are provided in closed systems packaging, are sterile, and are prepared for use with bioreactors. The microcarriers are additionally surface-treated to improve cell adhesion and increase cell production and survival.

COVID-19 Impact

The pandemic had a positive impact on the microcarrier market. The virus spread rapidly through transmission. Pharmaceutical companies stepped forward to develop vaccines to combat the rising risk of COVID-19. Many organizations pushed their efforts of research and development to develop vaccines and drugs against the coronavirus. Furthermore, government and world organizations provided funding to increase the research on vaccines for the deadly coronavirus, which further increased the demand for cell culture products, including microcarrier products during the pandemic.

Market Segmentation:

• By Product type

Equipment

Consumables

Reagents

Microcarrier Beads

Others

• By Application

Biopharmaceutical Production

Cell and gene therapy

Others

• By End-Users

Pharmaceuticals & Biotechnology Companies

Research Institutes

Contract Research Organizations

• By Geography

North America

• USA
• Canada
• Mexico

South America

• Brazil
• Argentina
• Others

Europe

• United Kingdom
• Germany
• France
• Spain
• Others

Middle East and Africa

• Saudi Arabia
• UAE
• Israel
• Others

Asia Pacific

• China
• India
• Japan
• South Korea
• Indonesia
• Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. COVID-19 Scenario
• 1.3. Market Definition
• 1.4. Market Segmentation

2. RESEARCH METHODOLOGY

• 2.1. Research Data
• 2.2. Assumptions

3. EXECUTIVE SUMMARY

• 3.1. Research Highlights

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Force Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. MICROCARRIERS MARKET, BY PRODUCT TYPE

• 5.1. Introduction
• 5.2. Equipment
• 5.3. Consumables
  • 5.3.1. Reagents
  • 5.3.2. Microcarrier Beads
  • 5.3.3. Others

6. MICROCARRIERS MARKET, BY APPLICATION

• 6.1. Introduction
• 6.2. Biopharmaceutical Production
• 6.3. Cell and gene therapy
• 6.4. Others

7. MICROCARRIERS MARKET, BY END-USER

• 7.1. Introduction
• 7.2. Pharmaceuticals & Biotechnology Companies
• 7.3. Research Institutes
• 7.4. Contract Research Organizations

8. MICROCARRIERS MARKET, BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. United States
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. United Kingdom
  • 8.4.2. Germany
  • 8.4.3. France
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. The Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Israel
  • 8.5.4. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Emerging Players and Market Lucrative
• 9.3. Mergers, Acquisition, Agreements, and Collaborations
• 9.4. Vendor Competitiveness Matrix

10. COMPANY PROFILES

• 10.1. Thermo Fisher Scientific
• 10.2. Corning Incorporated
• 10.3. Sartorious AG
• 10.4. Pall Corporation
• 10.5. Batavia Biosciences B.V.
• 10.6. Primorigen Biosciences
• 10.7. Cytiva
• 10.8. Nucleus Biologics, LLC.
• 10.9. Merck KGaA
• 10.10. Entegris